| Product NDC: | 0069-0242 |
| Proprietary Name: | Toviaz |
| Non Proprietary Name: | fesoterodine fumarate |
| Active Ingredient(s): | 4 mg/1 & nbsp; fesoterodine fumarate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-0242 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022030 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081031 |
| Package NDC: | 0069-0242-68 |
| Package Description: | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0242-68) |
| NDC Code | 0069-0242-68 |
| Proprietary Name | Toviaz |
| Package Description | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0242-68) |
| Product NDC | 0069-0242 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fesoterodine fumarate |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20081031 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | FESOTERODINE FUMARATE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |